Zerebrale Venenthrombosen im Zeitalter der COVID-19-Pandemie
- 27 October 2021
- journal article
- Published by Springer Science and Business Media LLC in CardioVasc
- Vol. 21 (5), 34-38
- https://doi.org/10.1007/s15027-021-3569-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet ImmunologyJournal of Thrombosis and Haemostasis, 2021
- Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysisEuropean Journal of Neurology, 2021
- Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosisJournal of Thrombosis and Thrombolysis, 2020
- Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous ThrombosisJAMA Neurology, 2019
- Cerebral Venous Thrombosis HeadacheCurrent Pain and Headache Reports, 2019
- Cerebral venous thrombosis: state of the art diagnosis and managementNeuroradiology, 2018
- Cerebral venous thrombosisNature Reviews Neurology, 2017
- European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of NeurologyEuropean Stroke Journal, 2017
- Cerebral venous thrombosis: an updateThe Lancet Neurology, 2007
- Prognosis of Cerebral Vein and Dural Sinus ThrombosisStroke, 2004